Apigenin suppresses colorectal cancer cell proliferation, migration and invasion via inhibition of the Wnt/β-catenin signaling pathway

Xu,Min; Wang,Shusheng; Song,Yu; Yao,Jianhua; Huang,Kun; Zhu,Xiaojue

doi:10.3892/ol.2016.4331

Apigenin suppresses colorectal cancer cell proliferation, migration and invasion via inhibition of the Wnt/β-catenin signaling pathway

Authors:
- Min Xu
- Shusheng Wang
- Yu Song
- Jianhua Yao
- Kun Huang
- Xiaojue Zhu
View Affiliations

Affiliations: Department of Hematology, Zhangjiagang Hospital, Suzhou University, Suzhou, Jiangsu 215600, P.R. China, Department of Surgery, Zhangjiagang Hospital, Suzhou University, Suzhou, Jiangsu 215600, P.R. China, Department of Oncology, Zhangjiagang Hospital, Suzhou University, Suzhou, Jiangsu 215600, P.R. China, Clinical Laboratory, Zhangjiagang Hospital, Suzhou University, Suzhou, Jiangsu 215600, P.R. China
Published online on: March 16, 2016 https://doi.org/10.3892/ol.2016.4331
Pages: 3075-3080

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Abnormal activation of the Wnt/β-catenin signaling pathway has a significant role in human tumorigenesis. The search for potential anticancer drugs has included widespread screening of inhibitors of the Wnt signaling pathway. Recently, one of the most common flavonoids, apigenin, demonstrated potential anti‑tumor effects on multiple human cancer cell lines, with low cytotoxicity and no mutagenic activity. However, the association between apigenin and the Wnt/β‑catenin signaling pathway remains to be elucidated. The results of wound healing and Transwell invasion assays revealed that apigenin was able to significantly suppress colorectal cancer cell proliferation, migration and invasion in a dose‑dependent manner. An organoid culture assay revealed that apigenin was also able to suppress the growth of intestinal organoids. Furthermore, apigenin inhibited β-catenin/T-cell factor/lymphoid enhancer factor signaling activation, which was induced by LiCl in a dose‑dependent manner. This inhibited β‑catenin nuclear entry, and therefore the expression of Wnt downstream target genes. In conclusion, apigenin significantly suppressed colorectal cancer cell proliferation, migration, invasion and organoid growth by inhibiting the Wnt/β-catenin signaling pathway.

View Figures

View References

1	Arend RC, Londoño-Joshi AI, Straughn JM Jr and Buchsbaum DJ: The Wnt/β-catenin pathway in ovarian cancer: A review. Gynecol Oncol. 131:772–779. 2013. View Article : Google Scholar : PubMed/NCBI
2	Noguti J, De Moura CF, Hossaka TA, Franco M, Oshima CT, Dedivitis RA and Ribeiro DA: The role of canonical WNT signaling pathway in oral carcinogenesis: A comprehensive review. Anticancer Res. 32:873–878. 2012.PubMed/NCBI
3	Pecina-Slaus N: Wnt signal transduction pathway and apoptosis: A review. Cancer Cell Int. 10:222010. View Article : Google Scholar : PubMed/NCBI
4	Moon RT, Brown JD and Torres M: WNTs modulate cell fate and behavior during vertebrate development. Trends Genet. 13:157–162. 1997. View Article : Google Scholar : PubMed/NCBI
5	Behrens J: Control of beta-catenin signaling in tumor development. Ann NY Acad Sci. 910:21–35. 2000. View Article : Google Scholar : PubMed/NCBI
6	Chesire DR, Ewing CM, Sauvageot J, Bova GS and Isaacs WB: Detection and analysis of beta-catenin mutations in prostate cancer. Prostate. 45:323–334. 2000. View Article : Google Scholar : PubMed/NCBI
7	Polakis P: The oncogenic activation of beta-catenin. Curr Opin Genet Dev. 9:15–21. 1999. View Article : Google Scholar : PubMed/NCBI
8	Birt DF, Mitchell D, Gold B, Pour P and Pinch HC: Inhibition of ultraviolet light induced skin carcinogenesis in SKH-1 mice by apigenin, a plant flavonoid. Anticancer Res. 17:85–91. 1997.PubMed/NCBI
9	Caltagirone S, Rossi C, Poggi A, Ranelletti FO, Natali PG, Brunetti M, Aiello FB and Piantelli M: Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. Int J Cancer. 87:595–600. 2000. View Article : Google Scholar : PubMed/NCBI
10	Wang IK, Lin-Shiau SY and Lin JK: Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells. Eur J Cancer. 35:1517–1525. 1999. View Article : Google Scholar : PubMed/NCBI
11	Wang W, Heideman L, Chung CS, Pelling JC, Koehler KJ and Birt DF: Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines. Mol Carcinog. 28:102–110. 2000. View Article : Google Scholar : PubMed/NCBI
12	Yin F, Giuliano AE, Law RE and Van Herle AJ: Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells. Anticancer Res. 21:413–420. 2001.PubMed/NCBI
13	Zhu Y, Mao Y, Chen H, Lin Y, Hu Z, Wu J, Xu X, Xu X, Qin J and Xie L: Apigenin promotes apoptosis, inhibits invasion and induces cell cycle arrest of T24 human bladder cancer cells. Cancer Cell Int. 13:542013. View Article : Google Scholar : PubMed/NCBI
14	Wang YJ, Zhou SM, Xu G and Gao YQ: Interference of Phenylethanoid Glycosides from Cistanche tubulosa with the MTT Assay. Molecules. 20:8060–8071. 2015. View Article : Google Scholar : PubMed/NCBI
15	Feliciangeli S, Bendahhou S, Sandoz G, Gounon P, Reichold M, Warth R, Lazdunski M, Barhanin J and Lesage F: Does sumoylation control K2P1/TWIK1 background K+ channels? Cell. 130:563–569. 2007. View Article : Google Scholar : PubMed/NCBI
16	Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, Stange DE, van Es JH, Abo A, Kujala P, Peters PJ and Clevers H: Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature. 459:262–265. 2009. View Article : Google Scholar : PubMed/NCBI
17	Miao L, Xiong X, Lin Y, Cheng Y, Lu J, Zhang J and Cheng N: MiR-203 inhibits tumor cell migration and invasion via caveolin-1 in pancreatic cancer cells. Oncol Lett. 7:658–662. 2014.PubMed/NCBI
18	Schuijers J, Junker JP, Mokry M, Hatzis P, Koo BK, Sasselli V, van der Flier LG, Cuppen E, van Oudenaarden A and Clevers H: Ascl2 acts as an R-spondin/Wnt-responsive switch to control stemness in intestinal crypts. Cell stem cell. 16:158–170. 2015. View Article : Google Scholar : PubMed/NCBI
19	Osada T, Chen M, Yang XY, Spasojevic I, Vandeusen JB, Hsu D, Clary BM, Clay TM, Chen W, Morse MA and Lyerly HK: Antihelminth compound niclosamide downregulates Wnt signaling and elicits antitumor responses in tumors with activating APC mutations. Cancer Res. 71:4172–4182. 2011. View Article : Google Scholar : PubMed/NCBI
20	Shen X, Ying H and Yue BY: Wnt activation by wild type and mutant myocilin in cultured human trabecular meshwork cells. PLoS One. 7:e449022012. View Article : Google Scholar : PubMed/NCBI
21	Haggar FA and Boushey RP: Colorectal cancer epidemiology: Incidence, mortality, survival and risk factors. Clin Colon Rectal Surg. 22:191–197. 2009. View Article : Google Scholar : PubMed/NCBI
22	Blair V, Kahokehr A and Sammour T: Cancer in Māori: Lessons from prostate, colorectal and gastric cancer and progress in hereditary stomach cancer in New Zealand. ANZ J Surg. 83:42–48. 2013. View Article : Google Scholar : PubMed/NCBI
23	Lazarova DL, Chiaro C, Wong T, Drago E, Rainey A, O'Malley S and Bordonaro M: CBP Activity Mediates Effects of the histone deacetylase inhibitor butyrate on WNT activity and apoptosis in colon cancer cells. J Cancer. 4:481–490. 2013. View Article : Google Scholar : PubMed/NCBI
24	Chong KY, Hsu CJ, Hung TH, Hu HS, Huang TT, Wang TH, Wang C, Chen CM, Choo KB and Tseng CP: Wnt pathway activation and ABCB1 expression account for attenuation of proteasome inhibitor-mediated apoptosis in multidrug-resistant cancer cells. Cancer Biol Ther. 16:149–159. 2015. View Article : Google Scholar : PubMed/NCBI
25	Jang GB, Hong IS, Kim RJ, Lee SY, Park SJ, Lee ES, Park JH, Yun CH, Chung JU, Lee KJ, et al: Wnt/beta-catenin small-molecule inhibitor CWP232228 preferentially inhibits the growth of breast cancer stem-like cells. Cancer Res. 75:1691–1702. 2015. View Article : Google Scholar : PubMed/NCBI
26	Hall CL, Zhang H, Baile S, Ljungman M, Kuhstoss S and Keller ET: p21CIP-1/WAF-1 induction is required to inhibit prostate cancer growth elicited by deficient expression of the Wnt inhibitor Dickkopf-1. Cancer research. 70:9916–9926. 2010. View Article : Google Scholar : PubMed/NCBI
27	Lin C, Lu W, Zhang W, Londoño-Joshi AI, Buchsbaum DJ, Bu G and Li Y: The C-terminal region Mesd peptide mimics full-length Mesd and acts as an inhibitor of Wnt/β-catenin signaling in cancer cells. PLoS One. 8:e581022013. View Article : Google Scholar : PubMed/NCBI
28	Sack U, Walther W, Scudiero D, Selby M, Aumann J, Lemos C, Fichtner I, Schlag PM, Shoemaker RH and Stein U: S100A4-induced cell motility and metastasis is restricted by the Wnt/β-catenin pathway inhibitor calcimycin in colon cancer cells. Mol Biol Cell. 22:3344–3354. 2011. View Article : Google Scholar : PubMed/NCBI
29	Seo HS, Ku JM, Choi HS, Woo JK, Jang BH, Shin YC and Ko SG: Induction of caspase-dependent apoptosis by apigenin by inhibiting STAT3 signaling in HER2-overexpressing MDA-MB-453 breast cancer cells. Anticancer Res. 34:2869–2882. 2014.PubMed/NCBI
30	Wu DG, Yu P, Li JW, Jiang P, Sun J, Wang HZ, Zhang LD, Wen MB and Bie P: Apigenin potentiates the growth inhibitory effects by IKK-β-mediated NF-κB activation in pancreatic cancer cells. Toxicol Lett. 224:157–164. 2014. View Article : Google Scholar : PubMed/NCBI
31	Chunhua L, Donglan L, Xiuqiong F, Lihua Z, Qin F, Yawei L, Liang Z, Ge W, Linlin J, Ping Z, et al: Apigenin up-regulates transgelin and inhibits invasion and migration of colorectal cancer through decreased phosphorylation of AKT. J Nutr Biochem. 24:1766–1775. 2013. View Article : Google Scholar : PubMed/NCBI
32	Wang QR, Yao XQ, Wen G, Fan Q, Li YJ, Fu XQ, Li CK and Sun XG: Apigenin suppresses the growth of colorectal cancer xenografts via phosphorylation and up-regulated FADD expression. Oncol Lett. 2:43–47. 2011.PubMed/NCBI